Aldose reductase inhibitor increases doxorubicin-sensitivity of colon cancer cells and decreases cardiotoxicity. [electronic resource]
Producer: 20181227Description: 3182 p. digitalISSN:- 2045-2322
- ATP Binding Cassette Transporter, Subfamily B, Member 1 -- genetics
- ATP Binding Cassette Transporter, Subfamily G, Member 2 -- genetics
- Aldehyde Reductase -- antagonists & inhibitors
- Animals
- Cardiotoxicity -- drug therapy
- Cell Proliferation
- Colonic Neoplasms -- drug therapy
- Doxorubicin -- administration & dosage
- Drug Resistance, Neoplasm -- genetics
- Gene Expression Regulation, Neoplastic -- drug effects
- HT29 Cells
- Humans
- Imidazolidines -- administration & dosage
- Mice
- Multidrug Resistance-Associated Proteins -- genetics
- Neoplasm Proteins -- genetics
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.